Company
Every investor coverage indicates participated in a round Macrobiome Therapeutics raised.
Companies Macrobiome Therapeutics acquired or merged with, per published coverage. Buying a company is not investing in one: nothing here counts in the deals column.
Stories naming Macrobiome Therapeutics. Where several outlets covered the same round, they are bundled under whichever ran the fullest account.
Profile of deep tech investor Main Sequence covering Elaine Stead's promotion to Partner, portfolio unicorns Gilmour Space and Advanced Navigation, CSIRO's expanded Atmosphere backing, and a fourth fund now being raised.
Also OIF Ventures portfolio·OIF Ventures portfolio·SmartCompany·@AuManufacturing·SmartCompany·SmartCompany·SmartCompany·@AuManufacturing·Forbes Australia
Main Sequence announces Elaine Stead's promotion to Partner while preparing its fourth fund; CSIRO has lifted its commitment to the firm's Atmosphere pre-seed program, and two portfolio companies have reached unicorn status.